SALT LAKE CITY, Nov. 4, 2013 /PRNewswire/ -- USANA Health
Sciences Inc. (NYSE: USNA) is building a state-of-the-art facility
in Beijing. The approximately
$40 million structure will house
world-class manufacturing and production operations. Upon
completion, the nearly 319,000-square-foot site will be the largest
in all of USANA's 19 international markets.
(Logo:
http://photos.prnewswire.com/prnh/20120807/LA53885LOGO)
"Our plans to invest in a high-tech production facility in
Beijing reflect the significant
opportunity and potential we see for our business in mainland
China," said Dave Wentz, USANA's chief executive officer. "At
USANA, we demonstrate our commitment to providing our customers
with the highest quality nutritionals by manufacturing essentially
all of our products in-house. This amazing facility will further
that commitment."
USANA has negotiated land usage rights for this new building
with the Beijing Economic and Technological Development Area, which
houses a number of high-tech industries. The company anticipates
that construction on this facility will begin in 2014 and will be
operational during the latter part of 2015.
For more information about USANA's products and company, visit
USANA.com.
About USANA
Founded in 1992, USANA Health Sciences
(NYSE: USNA) is a U.S.-based nutritional company that manufactures
high-quality supplements and personal care, energy and
weight-management products in its FDA-registered facility in
Salt Lake City. USANA's products,
used by more than 600 professional athletes, are developed by the
company's award-winning team of scientists and sold directly
to Preferred Customers and Associates in 19 international
markets. Learn more about USANA (www.USANA.com) and
stay current with the official USANA blog
(www.whatsupUSANA.com), like us on the USANA Facebook
page (www.facebook.com/USANAhealthsciences), or
follow USANA on Twitter (@USANAinc).
Safe Harbor
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act and Section 21E of the Securities Exchange
Act. Our actual results could differ materially from those
projected in these forward-looking statements, which involve a
number of risks and uncertainties, including global economic
conditions generally, reliance upon our network of independent
Associates, the governmental regulation of our products,
manufacturing and marketing risks, adverse publicity risks, and
risks associated with our international expansion. The
contents of this release should be considered in conjunction with
the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission.
Media Contact: Ashley Collins
Executive Director of PR, Social Media and Communications
USANA Health Sciences, Inc.
(801) 954-7629
media(at)us.usana(dot)com
SOURCE USANA Health Sciences Inc.